Dai Maruyama

53PUBLICATIONS
62CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyTumour immunologyOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jun 15, 2026
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial.

|Apr 14, 2026
Extracellular Vesicle IL5RA and BCMA in Serum Enable Non-Invasive Risk Stratification of Multiple Myeloma.

Yuko Shirouchi, Hiroki Shinchi, Yoshimi Haga

|Mar 31, 2026
Isatuximab induces antitumor activity in blastic plasmacytoid dendritic cell neoplasm through cellular cytotoxicity.

Nobuhiko Yamauchi, Yuko Mishima, Tomoko Takayama

|Feb 11, 2026
Long-term clinical outcomes of patients with localized primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.

Ritsuko Nakai, Dai Maruyama, Akiko Miyagi-Maeshima

|Jan 27, 2026
Novel agents and therapeutic advances in T cell lymphoma.

Yuko Shirouchi, Dai Maruyama

|Dec 20, 2025
Impact of Achieving Progression-Free Survival 24 on Subsequent Overall Survival in Diffuse Large B-Cell Lymphoma Patients.

Ayumi Fujimoto, Wataru Munakata, Gakuto Ogawa

Pageof 9

Frequent Collaborators

7 joint publications

Shinichi Makita

6 joint publications

Shinsuke Iida

6 joint publications

Kana Miyazaki

6 joint publications

Junya Kuroda